Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Group (TSE:CRON)
TSX:CRON
Cronos Group (CRON) Stock Price & Analysis
394 Followers
CRON Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$2.15 - C$4.28
Previous CloseC$3.99
Volume399.19K
Average Volume (3M)275.56K
Market Cap
C$1.52B
Enterprise ValueC$355.47M
Total Cash (Recent Filing)$855.11M
Total Debt (Recent Filing)$2.26M
Price to Earnings (P/E)-19.7
Beta0.77
Next Earnings
Aug 08, 2024EPS Estimate
>-C$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding381,298,853
10 Day Avg. Volume279,264
30 Day Avg. Volume275,559
Standard Deviation0.15
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.06
Price to Sales (P/S)65.51
Price to Cash Flow (P/CF)-127.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.14
Enterprise Value/Gross Profit29.85
Enterprise Value/Ebitda-85.47
Forecast
1Y Price Target
C$3.76Price Target Upside-5.75% Downside
Rating ConsensusHold
Number of Analyst Covering5
Cronos Group News
PremiumCompany Announcements
Cronos Group Soars with Robust Q1 EarningsBulls Say, Bears Say
Bulls Say
Market OutlookCannabis stocks rally on growing optimism for reform with expectations of increased medical cannabis sales due to regulatory changes in Germany and Israel, and potential rule alterations in Canada.
Product SuccessCronos reports impressive success with new value-add products under the Spinach brand, indicating robust product innovation and market acceptance.
Strategic MergersCronos shareholders could benefit from the upside potential if the company engages in a strategic merger with another cannabis firm, particularly if the deal is structured in stock.
Bears Say
Financial PerformanceCronos' financial performance has shown trends of worsening in the fourth quarter, with a drop in gross margins and high selling, general and administrative expenses, raising concerns about long-term value creation.
Market DynamicsDue to the ongoing conflict and increased competition in Israel, sales forecasts for Cronos have been reduced, which could negatively impact the stock's performance.
Regulatory EnvironmentAnalyst remains cautious on US reform, as an election year normally adds to the gridlock in Congress, potentially delaying progress in the cannabis industry.
---
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was C$2.15 and its highest was C$4.28 in the past 12 months.
What is Cronos Group’s market cap?
Currently, no data Available
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Aug 08, 2024 which is in 81 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on May 09, 2024. The company reported -C$0.014 earnings per share for the quarter, the consensus estimate of -C$0.014 by C$0.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Overvalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is >-C$0.01.
How many shares outstanding does Cronos Group have?
Cronos Group has 382,011,170 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of -C$0.014 in its last earnings report, expectations of -C$0.014. Following the earnings report the stock price went up 9.244%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in TSE:CRON
---
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$3.76 (-5.75% Downside)
C$3.76 (-5.75% Downside)
Blogger Sentiment
Bullish
TSE:CRON Sentiment 78%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 6.1%
Last 30 Days ▲ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
65.71%
12-Months-Change
Fundamentals
Return on Equity
-4.91%
Trailing 12-Months
Asset Growth
-4.40%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
---
CRON Earnings Call
Q1 2024
0:00 / 0:00
---
CRON Stock 12 Month Forecast
Average Price Target
C$3.76
▼(-5.75% Downside)
Technical Analysis
Best Analysts Covering CRON
1 Year
1 Year Success Rate
13/20 ratings generated profit
1 Year Average Return
+15.58%
reiterated a buy rating 10 days ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 65.00% of your transactions generating a profit, with an average return of +15.58% per trade.
---